Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.005 AUD | -16.67% | -16.67% | 0.00% |
05-08 | Invion Partners with Hanlim Pharma for Glioblastoma Treatment | MT |
03-05 | Invion's Anti-Cancer Drug Logs Postive Preclinical Trial Results | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
0.00% | 25.47M | |
+30.12% | 48.16B | |
-0.82% | 41.73B | |
+42.66% | 41.03B | |
-5.26% | 28.77B | |
+10.15% | 25.59B | |
-22.65% | 18.96B | |
+9.12% | 12.92B | |
+29.25% | 12.03B | |
-1.98% | 11.77B |
- Stock Market
- Equities
- IVX Stock
- News Invion Limited
- Invion Grants RMW Cho Group Right to Distribute Cancer Treatment Products in South Korea